Approaching BAT in Market Value: What's Happening in Indian Tobacco Giant ITC Ltd

Business by 2FIRSTS Charlotte Yu
Mar.26.2024
Approaching BAT in Market Value: What's Happening in Indian Tobacco Giant ITC Ltd
ITC Ltd's market value is closing in on British American Tobacco at $640bn, sparking interest in the Indian tobacco giant.

According to a report by Moneycontrol, Indian tobacco giant ITC Ltd is catching up to British American Tobacco in terms of market value. Currently, ITC Ltd has a market value of $64 billion, just slightly below British American Tobacco's $68 billion.

 

British American Tobacco (BAT) recently sold its stake in ITC worth approximately 170 billion Indian rupees (2 billion USD). BAT's stock has dropped 21% in the past year, while ITC's stock has increased by around 11%.

 

Why is the market value of Indian tobacco rising so significantly? And how did two companies with intersecting links in capital reach the impending "turnaround" today?

 

2FIRSTS conducted an inventory and analysis of recent market trends and capital changes in the Indian tobacco industry.

 

Diversified Business

 

The headquarters of ITC are located in Kolkata, and approximately 75% of its pre-tax profits come from cigarettes. It is India's largest cigarette manufacturer, with three out of every four legally sold cigarettes produced by ITC.

 

As a diversified conglomerate, ITC has recently become India's largest fast-moving consumer goods (FMCG) producer and operates the country's second-largest hotel chain. It is also India's largest private agricultural enterprise and operates the country's largest paper industry.

 

In 2023, the board of directors approved the split of ITC's hotel business. CEO of British American Tobacco (BAT), Tadeu Marroco, remarked that ITC's stock price is undervalued compared to other consumer goods competitors. The separation of the hotel business will provide greater flexibility for future capital allocation.

 

ITC is a company that has consistently performed exceptionally well. In terms of financial performance, it has added value compared to BAT, with its stock performing very strongly in recent years. It remains undervalued compared to most fast-moving consumer goods companies in India.... Therefore, there is still plenty of opportunity for further growth in ITC's stock price. We believe that ITC has a long way to go in terms of future stock performance and value creation.

 

ITC and BAT: Tangled Web of Capital Connections 

 

Approaching BAT in Market Value: What's Happening in Indian Tobacco Giant ITC Ltd
BAT Logo 

 

Despite their optimism, BAT withdrew their investment in ITC in 2023.

 

British American Tobacco (BAT) initially invested in ITC in the early 1900s. Prior to the recent sale, BAT held approximately 29% of the shares in ITC, making it the largest shareholder. BAT also had two representatives on the board of directors at ITC, and frequently provided input and raised questions regarding the company's operations.

 

In December 2023, during the annual earnings update conference call for BAT, CEO Marroco told analysts that BAT does not need to hold more than 25% of the shares in ITC to have strategic influence and veto power. Therefore, they are considering divesting. Marroco also mentioned two major challenges to divesting from ITC. The first is India's foreign direct investment rules for the tobacco industry, particularly the "prohibition of international companies investing in the Indian tobacco industry." Any actions taken by BAT regarding their shares require specific approval from the Reserve Bank of India, which Marroco believes "greatly increases bureaucracy and operating costs." Therefore, BAT has made the decision to sell their shares.

 

New Market: High-end Nicotine and Novel Derivatives

 

ITC Corporation's recent strong momentum largely stems from its continuous innovation. In the past five years, the number of new products launched by ITC has increased by over five times, accounting for nearly 17% of total sales. Furthermore, its management announced at the end of 2023 that the company will venture into another potential market worth $500 million: the export market for premium nicotine and its derivative products.

 

During the investor conference held in December 2023, the management of ITC explicitly stated in discussions with analysts that nicotine has been identified as one of the new growth drivers for the diversified agriculture enterprise.

 

Due to the increasing global demand for premium nicotine products, the profit margins are high. This is because the processing of such products is quite complex, leading to a high entry barrier. Additionally, Indian tobacco is known for its high nicotine content, giving it promising growth prospects.

 

The advantage of ITC lies in its powerful procurement capabilities, which enable it to achieve a seamless supply chain from farm to cigarette packet. The result of streamlining the supply chain is the ability to provide complete traceability, which solves a major pain point in the still "wildly growing" new tobacco market.

 

ITC expects to see growth in new nicotine products such as flavored capsules under stable tax policies. However, due to a high base, recent growth may level off. Cigarette sales for ITC (fiscal year 2024) are expected to return to the levels seen in fiscal year 2013 (with a projected annual compound growth rate of around 3.75% for fiscal years 2019-24). ITC management has stated that the export of food technology and nicotine derivatives will create significant value for shareholders in the coming years.

 

2FIRSTS will continue to track developments of tobacco companies in India.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Korea’s MFDS sets 2026 plan to manage and disclose harmful constituents in tobacco products
Korea’s MFDS sets 2026 plan to manage and disclose harmful constituents in tobacco products
South Korea’s Ministry of Food and Drug Safety (MFDS) said it has established its 2026 work plan to systematically manage harmful constituents in tobacco products and disclose related information under the Tobacco Harmfulness Management Act, which took effect in November 2025.
Jan.16 by 2FIRSTS.ai
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
During the “Toxicological Profile” session at FDA’s Feb 10 PMTA roundtable, officials outlined the carcinogenicity tiering system and Excess Lifetime Cancer Risk (ELCR) framework used in ENDS reviews under the APPH standard. Small manufacturers questioned database transparency, exposure assumptions, and the existence of clear compliance benchmarks. FDA reiterated toxicological risk is assessed case by case within a broader population-level determination.
Feb.11
Philippine FDA Requires Licenses for Vape Products with Medical Claims
Philippine FDA Requires Licenses for Vape Products with Medical Claims
The Philippine Food and Drug Administration has announced that establishments selling vaporized nicotine and non-nicotine products and novel tobacco products with medicinal or therapeutic claims must secure Licenses to Operate. Such products are also required to be registered as pharmaceutical products through the Center for Drug Regulation and Research. The FDA urged stakeholders to comply with the new requirements to ensure product safety, efficacy and quality.
Dec.22 by 2FIRSTS.ai
San Francisco reaches $1 million settlement with nicotine pouch retailer Lucy Goods
San Francisco reaches $1 million settlement with nicotine pouch retailer Lucy Goods
In the United States, California, San Francisco City Attorney David Chiu announced a $1 million settlement requiring online tobacco retailer Lucy Goods, Inc. to stop shipping illegal tobacco products into San Francisco.
Jan.09 by 2FIRSTS.ai
UK vape firm Plxsur sold for £76,500 after touting $1 billion revenue target
UK vape firm Plxsur sold for £76,500 after touting $1 billion revenue target
London-based vaping company Plxsur, which had claimed in fundraising materials it could reach $1 billion in annual revenue and capture about 10% of the global vaping market, has been sold out of administration for £76,500. Administrators said the figures were aspirational and depended on acquisitions that were never completed, as the company later ran out of cash and entered insolvency, with a shareholder ultimately buying the business.
Jan.22 by 2FIRSTS.ai
Authorities in Kazakhstan Seize Over 53,000 Illegal Vape Products in Pavlodar
Authorities in Kazakhstan Seize Over 53,000 Illegal Vape Products in Pavlodar
Kazakhstan’s Financial Monitoring Agency in Pavlodar Region has concluded an investigation into an organised group involved in the illegal sale of vaping products. The group operated through three Telegram-based online shops and used courier delivery services. Authorities seized more than 53,000 items, with a total value exceeding 400 million tenge. The investigation found that students were the primary consumers. Four suspects have been placed in custody and multiple assets have been seized.
Dec.25 by 2FIRSTS.ai